The challenge of gaining reimbursements as well as regulatory approval is becoming more and more prevalent and many pharmaceutical developers are now realizing the importance of evidence in clinical trials. Although evidence is essential it’s important that it’s also in line with cost effectiveness. This can be done by following these three steps:
1. Review previous submissions for compounds similar to your own to avoid making the mistakes others have made before
2. Make sure you have a large sample group to compare overall survival rates for the groups in your clinical trial
3. Carry out a power analysis remembering that the larger a trial, the greater its power and as a result the greater its cost.